Clinical Trial Update: Hydros and Hydros-TA Joint Therapy for Pain Associated With Knee Osteoarthritis [Phase 3]

View source ↗

Summary

Phase 3 trial of Hydros and Hydros-TA Joint Therapy for knee osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Hydros
• Hydros-TA Joint Therapy

Snippet

Sponsor: Carbylan Therapeutics, Inc. | Conditions: Osteoarthritis of the Knee | Phase 3 | Status: COMPLETED